Readify

Peter Jahrling

The Hot Zone

Peter Jahrling is a civilian virologist at the United States Army Medical Research Institute of Infectious Diseases whose work helped identify Ebola in the Reston monkey outbreak. A specialist in dangerous and unfamiliar viruses, he moved between controlled laboratory procedures and the possibility that the agent he was studying had reached him as well. The contrast at the heart of his story is stark: he and Tom Geisbert recognized a virus related to Ebola Zaire in the monkeys, but the feared human illness did not follow among the exposed workers and researchers.

Identity and Work

Jahrling had spent most of his career at the Institute after an earlier period in Central America, where he searched rain forests for viruses and discovered several previously known strains. His research included vaccines and drug treatments for dangerous viruses, as well as basic studies of rain-forest agents. The unknown and deadly were his specialty, although he deliberately tried not to dwell on what infection by such an agent might mean. He had handled nearly every known hot agent except Ebola and Marburg, and his stated reluctance to work with those viruses reflected the personal risk behind his expertise.

That expertise coexisted with an ordinary suburban routine. Jahrling, his wife, and their three children lived in Thurmont, near Nancy Jaax and Jerry Jaax, though the families did not socialize. He kept his lawn neat and drove to work in a brown car whose vanity plate read LASSA, after a Level 4 virus from West Africa that he considered fascinating. The plate offered an inconspicuous sign of the specialized world he entered each day: most neighbors had little idea that the car was taking him to work with dangerous pathogens.

The Samples from Reston

On Monday, November 13, Dan Dalgard contacted Jahrling about sick monkeys and asked him to help identify the disease. Dalgard suspected simian hemorrhagic fever, and Jahrling agreed to examine samples. The next day, frozen monkey tissue, throat wash, and blood serum arrived at the Institute in aluminum foil. The melting ice had begun to drip. Jahrling carried the material into a Level 3 laboratory, where negative air pressure helped prevent anything from escaping, though staff did not need the full protective suits worn in the highest-containment spaces.

The improvised packaging made the danger of handling biological material concrete. Jahrling and a pathologist unwrapped the monkey spleen, while Jahrling considered how carelessly the sample had been sent. He later called Dalgard to explain that samples should be packaged so they would not drip onto the laboratory carpet. The incident was a small but consequential reminder that containment depended not only on sophisticated facilities, but also on mundane choices in transporting and handling specimens.

The laboratory team cultured the unknown agent in living monkey cells. Joan Rhoderick prepared samples from the spleen, throat mucus, and serum, placing them in flasks in a warm incubator. As the cells changed and died, the tests indicated that the agent was multiplying. Meanwhile, the monkeys’ condition appeared briefly to improve, and Dalgard was relieved. That apparent lull ended when eight monkeys in Room F stopped eating and the outbreak worsened again. The changing animal cases made diagnosis urgent: the samples were not an abstract laboratory puzzle, but evidence from an outbreak that had resumed its course.

Recognizing Ebola

On November 27, Tom Geisbert brought photographs of the agent to Jahrling’s office. The images showed a filovirus in samples from the Reston monkeys. Geisbert thought it might be Marburg, but the particles appeared longer than the characteristic forms he associated with that virus. Jahrling examined the photographs, compared them with a textbook, and decided to show them to C. J. Peters. The images did not yet settle the identification; they narrowed the question and made the consequences of a wrong answer more serious.

Jahrling’s decisive test compared the monkey-culture material against blood sera associated with known viruses. Wearing a space suit in a dark Level 4 laboratory closet, he examined slides under a microscope. The sample associated with Shem Musoke did not glow; the Boniface sample glowed weakly; the serum from Nurse Mayinga N. glowed brightly. The result indicated that the Reston agent was Ebola, not Marburg, and that it was closely related to Ebola Zaire. Because the apparent match was so consequential, Jahrling repeated the test while carefully tracking his vials, bottles, and slides. The Mayinga serum reacted again.

The microscope transformed a faint signal into a finding with immediate institutional consequences. Jahrling called C. J. Peters from inside the laboratory, still wearing his suit, and reported that the result was real and identified Ebola. To transfer the results out of the hot zone, he placed the written findings in a disinfecting pass-through tank. Peters received the sterilized paper on the other side, then directed Jahrling to leave the laboratory so they could take the discovery to the Institute’s commander. The result moved from a laboratory observation into the military chain of command.

Exposure and Uncertainty

The identification also turned the investigation back on its investigators. Jahrling and Geisbert had been working with the samples, and Jahrling worried that they might have been exposed. In the weeks that followed, he continued daily work in a space suit, testing monkey samples and trying to isolate a pure specimen while Geisbert worked long hours at the microscope. Their conversations about whether either felt unwell were brief checks against the possibility of infection, not a resolution of it.

Jahrling also tested his own blood. In the dark closet, he looked for a change in its faint normal glow that would indicate Ebola. He understood that interpreting the slide was not simply a matter of seeing light: he had to decide how much to trust his instruments and his own perception. Neither his blood nor Geisbert’s reacted to the test. The negative result was reassuring, but it could not settle the question immediately; they still had to pass through the incubation period. At the end of one long shift, Jahrling fell asleep during the seven-minute decontamination cycle, exhausted and still inside his suit. The final water jets woke him before the cycle ended.

By the nineteenth day after the exposure incident, the absence of symptoms had led Jahrling and Geisbert to regard themselves as survivors. Dalgard and the monkey workers had also shown no signs of developing Ebola disease. This produced an unresolved contrast: the agent killed monkeys in large numbers, yet those who had handled or worked around them did not become ill. Investigators traced the monkeys to the Ferlite Farms monkey-storage facility near Manila, where animals had also been dying, without apparent illness among the Philippine workers. The origin and behavior of the virus remained puzzling even as the immediate human danger appeared to recede.

Aftermath and Significance

Jahrling and Geisbert named the strain Reston, after the place where it was first noticed. Jahrling later became a principal scientist at the Institute. His survival did not make him confident that the outbreak had been harmless. He argued that the exposed workers may have acquired the virus through the air and warned against treating the Reston strain as automatically safe merely because it had not caused recognized illness in people. In his view, a future virus that looked similar might not share the same limits.

That caution gives Jahrling’s role its wider significance. His work established the viral identity through a chain of practical steps—properly interpreted samples, repeated testing, microscopic comparison, and communication through containment procedures—while the result resisted easy conclusions about transmission and human risk. The reassuring negative tests mattered, but so did their limits. Jahrling’s account of the episode remained shaped by that distinction: identifying the agent was possible; knowing exactly what it could do in people was not.